Lack of apoptosis in mitochondrial encephalomyopathies

Neurology

Volumn 56, Issue 8, 2001, Pages 1070-1074

  Sciacco, M ^a   Fagiolari, G ^a   Lamperti, C ^a   Messina, S ^a   Bazzi, P ^a   Napoli, L ^a   Chiveri, L ^a   Prelle, A ^a   Comi, G P ^a   Bresolin, N ^a   Scarlato, G ^a   Moggio, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; DNA FRAGMENT; DNA NUCLEOTIDYLEXOTRANSFERASE; FAS ANTIBODY; MITOCHONDRIAL DNA; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENCEPHALOMYOPATHY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MORPHOGENESIS; MUSCLE BIOPSY; NEUROLOGIC DISEASE; NICK END LABELING; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE;

EID: 0035942360     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.8.1070     Document Type: Article

References (42)

1. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease
2. Mitochondria in neuromuscular disorders
3. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome
4. Mitochondrial respiratory chain disorders I: Mitochondrial DNA defects
5. Mitochondrial respiratory chain disorders II: Neurodegenerative disorders and nuclear gene defects
6. Defining apoptosis
7. Apoptosis in neurodegenerative disorders
8. Mitochondria and apoptosis
9. Lonidamine triggers apoptosis via a direct, Bcl-2 inhibited effect on the mitochondrial permeability transition pore
10. Mitochondrial release of caspase-2 and -9 during the apoptotic process
11. Apoptosis in metabolic myopathies
12. Apoptosis in mitochondrial encephalopathies with mitochondrial DNA mutations: A potential pathogenic mechanism
13. Alterations of surface morphology caused by the metabolism of menadione in mammalian cells are associated with the oxidation of critical sulfhydryl groups in cytoskeletal protein
14. Menadione-induced bleb formation in hepatocytes is associated with the oxidation of thiol groups in actin
15. Muscle biopsy
16. New morphological approaches to the study of mitochondrial encephalomyopathies
17. Cytochemistry and immunocytochemistry of mitochondria in tissue sections
18. Congenital myopathy associated with abnormal accumulation of desmin and dystrophin
19. Deletions of mitochondrial DNA in Kearns-Sayre syndrome
20. Two novel pathogenic point mitochondrial DNA mutations affecting organelle number and protein synthesis
21. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy
22. Cell death and oxidative damage in inflammatory myopathies
23. Cytotoxic mechanisms in inflammatory myopathies
24. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism
25. Neural apoptosis
26. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
27. The biochemistry of apoptosis
28. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA
29. Programmed cell death and Bcl-2 protection in very low oxygen
30. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
31. Mitochondrial control of nuclear apoptosis
32. Cytochrome c-mediated apoptosis in cells lacking mitochondrial DNA
33. Two CD95 (APO-1/Fas) signaling pathways
34. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells
35. Uncouplers of oxidative phosphorylation can enhance a Fas death signal
36. L in osteosarcoma cells
37. Somatic mutations of the mitochondrial genome in human colorectal tumors
38. Mitochondria as regulators of apoptosis: Doubt no more
39. Symmetric lesions of the subthalamic nuclei in mitochondrial encephalopathies: An almost distinctive mark of Leigh disease with COX deficiency
40. Cytochrome c oxidase deficiency presenting as recurrent neonatal myoglobinuria
41. The mitochondrial death/life regulator in apoptosis and necrosis